Search
Inhibikase Therapeutics Inc
IKTAdd to Watchlist
1.990USD
+0.050+2.58%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
262.74MMarket Cap
LossP/E TTM
Inhibikase Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-02The current valuation score of Inhibikase Therapeutics Inc is 6.54, ranking 324 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -4.59, which is -198.93% below the recent high of 4.54 and -1035.06% above the recent low of -52.14.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.